Page last updated: 2024-11-02

potassium chloride and Parkinson Disease

potassium chloride has been researched along with Parkinson Disease in 3 studies

Potassium Chloride: A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA.
potassium chloride : A metal chloride salt with a K(+) counterion.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Ross, A1
Xing, V1
Wang, TT1
Bureau, SC1
Link, GA1
Fortin, T1
Zhang, H1
Hayley, S1
Sun, H1
Yin, LH1
Shen, H1
Diaz-Ruiz, O1
Bäckman, CM1
Bae, E1
Yu, SJ1
Wang, Y1
Pearl, SM1
Antion, MD1
Stanwood, GD1
Jaumotte, JD1
Kapatos, G1
Zigmond, MJ1

Other Studies

3 other studies available for potassium chloride and Parkinson Disease

ArticleYear
Alleviating toxic α-Synuclein accumulation by membrane depolarization: evidence from an in vitro model of Parkinson's disease.
    Molecular brain, 2020, 07-31, Volume: 13, Issue:1

    Topics: alpha-Synuclein; Amyloid; Cell Death; Cell Differentiation; Cell Line, Tumor; Electric Stimulation;

2020
Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease.
    BMC neuroscience, 2012, Oct-06, Volume: 13

    Topics: Adrenergic Agents; Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dopaminer

2012
Effects of NADH on dopamine release in rat striatum.
    Synapse (New York, N.Y.), 2000, Volume: 36, Issue:2

    Topics: Animals; Antioxidants; Biopterins; Cell Culture Techniques; Dopamine; Extracellular Space; Male; NAD

2000